Tran, Tanja
,
Šterclová, Martina
Mogulkoc, Nesrin
Lewandowska, Katarzyna
Müller, Veronika
Hájková, Marta
Kramer, Mordechai R.
Jovanović, Dragana
Tekavec-Trkanjec, Jasna
Studnicka, Michael
Stoeva, Natalia
Hejduk, Karel
Dušek, Ladislav
Suissa, Samy http://orcid.org/0000-0002-1281-5296
Vašáková, Martina
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 9 August 2019
Accepted: 29 December 2019
First Online: 8 January 2020
Ethics approval and consent to participate
: This study was conducted in accordance with the ethical principles detailed in the Declaration of Helsinki and written informed consent was obtained from all patients. The study was approved by the Ethical Committee of the Thomayer Hospital, Prague, Czech Republic (approval no. 3195/14 (A 15–01-02)).
: Not applicable.
: S.S. has received research grants from Boehringer Ingelheim and Novartis and has participated in advisory board meetings or as speaker for AstraZeneca, Boehringer-Ingelheim, and Novartis. L.D. and K.H. have received grants from Boehringer-Ingelheim and Roche. J.T.-T. has received support from Boehringer-Ingelheim and Roche. None of the other authors have any competing interests to disclose.